Yahoo
NasdaqGS - Nasdaq Real Time Price USD

First Tracks Biotherapeutics, Inc. (TRAX)

45.05 -0.03 (-0.07%)
At close: November 2 at 4:00:00 PM EST
45.05 0.00 (0.00%)
After hours: November 2 at 4:33:53 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2024
12/31/2023
Total Revenue
0
0
0
Operating Expense
181,101
181,101
118,461
Operating Income
-181,101
-181,101
-118,461
Net Non Operating Interest Income Expense
17,382
17,382
12,313
Other Income Expense
14
14
-2
Pretax Income
-163,705
-163,705
-106,150
Net Income Common Stockholders
-163,705
-163,705
-106,150
Diluted NI Available to Com Stockholders
-163,705
-163,705
-106,150
Basic EPS
-4.71
--
-3.05
Diluted EPS
-4.71
--
-3.05
Basic Average Shares
34,748.84
--
34,748.84
Diluted Average Shares
34,748.84
--
34,748.84
Total Operating Income as Reported
-181,101
-181,101
-118,461
Total Expenses
181,101
181,101
118,461
Net Income from Continuing & Discontinued Operation
-163,705
-163,705
-106,150
Normalized Income
-163,705
-163,705
-106,150
Interest Income
17,382
17,382
12,313
Net Interest Income
17,382
17,382
12,313
EBIT
-181,101
-181,101
-118,461
EBITDA
-178,704
-178,704
-116,085
Reconciled Depreciation
2,397
2,397
2,376
Net Income from Continuing Operation Net Minority Interest
-163,705
-163,705
-106,150
Normalized EBITDA
-178,704
-178,704
-116,085
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2023 - 4/6/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: